etoposide has been researched along with nk 252 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiue, A; Kohno, K; Kuwano, M; Naito, A; Okumura, M; Sano, T | 1 |
| Kiue, A; Kohno, K; Kuwano, M; Takano, H; Watanabe, Y | 1 |
2 other study(ies) available for etoposide and nk 252
| Article | Year |
|---|---|
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice | 1991 |
Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents; Cell Survival; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Humans; Intracellular Fluid; Neoplasms; Tritium; Tumor Cells, Cultured; Vincristine | 1991 |